1) chronic myelogenous leukemia
慢性髓细胞性白血病
1.
Objective:To construct eukaryotic expression vector of siRNA specific for bcr/abl as a molecular target tool to cleave bcr/abl mRNA in chronic myelogenous leukemia cell, and to expore the feasibility of it.
目的:构建特异性的抗慢性髓细胞白血病融合基因bcr/ablmRNA的siRNA真核细胞表达载体,探索RNA干扰(RNAi)分子靶向治疗慢性髓细胞性白血病(CML)的作用。
2.
To clarify the association between HLA DPB1 alleles and chronic myelogenous leukemia (CML) in South Chinese, the allelic types of HLA DPB1 were detected by sequence based typing (SBT) in 86 patients with CML and 82 healthy individuals from Southern China.
为了探讨慢性髓细胞性白血病 (CML)与人类白细胞抗原 (HLA)DPB1基因的相关性和分析其遗传易感性 ,采用测序分型技术 (SBT)对 86例主要为广东藉的南方汉族CML患者和 82例健康对照者进行HLA DPB1基因分型。
3.
Objective: To investigate the effects of Calcium ionophore(CI) on the induction of chronic myelogenous leukemia cells into dendritic cells (CML-DCs).
目的：探讨钙离子载体诱导慢性髓细胞性白血病细胞分化生成树突状细胞的作用，探索一种更快速、简便、高效的获取大量树突状细胞的方法。
2) Chronic myeloid leukemia
慢性髓细胞性白血病
1.
Treatment of newly diagnosed chronic myeloid leukemia with imatinib united homoharringtonine
伊马替尼联合高三尖杉酯碱治疗初诊慢性髓细胞性白血病疗效观察
2.
Chronic myeloid leukemia is one of myeloid malignancies.
慢性髓细胞性白血病(Chronic myeloid leukemia, CML)是一种起源于造血干细胞的恶性增生性疾病,目前仍缺乏有效的治疗方法,复发的根源是白血病微小残余病变(minimal residue disease, MRD)。
3) CML
慢性髓细胞性白血病
1.
The RNAs extracted from one chronic myelogenous leukemia(CML) patient and one control sample were labelled with chemiluminescence method.
应用化学发光法标记技术分别对正常和临床慢性髓细胞性白血病(chronic myelogenous leukemia,CML)病人骨髓单个核细胞的RNA进行标记,然后与ABI的人全基因组表达谱芯片杂交,对于杂交后所得到的荧光信号数据,应用1700芯片分析系统对其进行生物信息学分析。
4) Chronic myelocytic leukemia
慢性髓细胞性白血病
1.
Relationship of chronic myelocytic leukemia and angiogenesis factors;
慢性髓细胞性白血病与血管生成因子关系
5) chronic myeloid leukemia cel l line
慢性髓性白血病细胞系
6) Chronic myeloid leukemia
慢性髓细胞白血病
1.
Chromosome analysis and quantification of bcr-abl fusion gene transcripts in patients with chronic myeloid leukemia: Value of clinical application;
慢性髓细胞白血病患者染色体分析及bcr／abl融合基因转录本定量的临床意义
2.
Immunoregulatory effects of interferon-α on dendritic cells from patients with chronic myeloid leukemia (Ⅱ);
α-干扰素对慢性髓细胞白血病来源的树突状细胞的免疫调节作用(Ⅱ)
3.
To investigate the karyotype of chronic myeloid leukemia in blast crisis (CML-BC), karyotype analysis was performed with R-banding technique in 119 patients with CML-BC.
为了探讨慢性髓细胞白血病急变期(CML-BC)核型变化规律及意义,应用R显带技术对119例CML-BC患者的核型资料进行分析,并在其中随机选出28例以荧光原位杂交法(FISH)检测衍生9号染色体[der(9)]是否缺失。
补充资料：慢性淋巴细胞性白血病
慢性淋巴细胞性白血病
简称"慢淋"。系免疫无能的小淋巴细胞恶性增殖性疾病。起病比慢粒更缓慢，临床表现更为多样化。早期常无症状或仅有轻度不适，可在体检或血细胞检验时偶然发现。首发症状为淋巴结肿大，其次为乏力、消瘦等。全身症状如发热、盗汗、瘙痒等多为疾病进展的征象。待疾病晚期贫血及出血同时出现。本病预后相对良好，患者又多为老年，所以不必由于淋巴细胞增多而急于治疗。症状明显者，一般采用化疗和放射治疗等。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条